PEN
Penumbra, Inc.
NYSE · Healthcare · Medical - Devices · US
$322.17
+0.32%Forward multiples
Based on analyst estimates
- P/E forward
- 58.11x
- P/E 2026E
- 68.45x
- P/E 2027E
- 53.80x
- P/E 2028E
- 46.13x
- P/S forward
- 7.49x
Trailing multiples
Trailing twelve months
- P/E TTM
- 78.77x
- PEG TTM
- 2.22x
- Price / book
- 8.29x
- Price / sales
- 8.43x
- Price / cash flow
- 45.68x
Enterprise value
- Enterprise value
- $12.2B
- EV / sales
- 8.14x
- EV / EBITDA
- 55.09x
- EV / EBIT
- 65.36x
- Market cap
- $12.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026